In this regard, emerging evidence suggests that combining dopaminergic imaging with molecular assays such as RT-QuIC for alpha-synuclein aggregation or other dementia markers can offer a more comprehensive diagnostic approach (24). This evidence concerns the gene SNCA and dementia.